Lasa Supergenerics logo

Lasa Supergenerics financials: balance sheet, profit and loss, cash flow

NSE: LASABSE: 540702Pharmaceuticals & BiotechnologySmall Cap

Lasa Supergenerics Limited · Face value ₹10 · Listed Sep 2017
Last close ₹4.67down ₹0.24 (4.89%)BSE ₹5.03

Share price at the NSE close on 26 Oct 2026. Previous close ₹4.91.

26 Oct: open ₹4.86, high ₹4.86, low ₹4.67

52-week range of traded prices to 26 Oct 2026
₹4.67Low, 26 Oct 2026₹12.48High, 5 Jan 2026
Market cap
₹23 Cr3,595th largest listed
P/E
Lossover the last 12 months
P/B
0.47
Dividend yield
Nonein the last 12 months
ROE
−24.8%
ROCE
−24.8%
Debt to equity
0.20
Volume, NSE
42,091

Lasa Supergenerics' financial statements for the 9 years to Mar 2026, standalone: the listed company alone, without its subsidiaries, with the twelve months to Jun 2026 after them.

9 years at a glance

₹ crore, years to March.Lasa Supergenerics annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
24612Mar 18170−1269Mar 191673.634Mar 20202230Mar 21137−5.40Mar 22130−390Mar 23104−2222Mar 24142−152.6Mar 2525−349.7Mar 26
Peak revenue ₹246 Cr, year to Mar 2018; lowest ₹25 Cr, year to Mar 2026A loss in 6 of the 9 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin
23.3%−135.6%16.8%6.6%17.9%23.3%11.4%−5.1%2.1%4.4%−113.0%5.0%−7.1%2.2%11.3%−3.9%−29.8%−20.8%−10.4%−135.6%Mar 18Mar 20Mar 22Mar 24Mar 26

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue25
  2. Materials and goods−24
  3. Employee costs−2.2
  4. Other expenses−28
  5. Operating profit−28
  6. Depreciation−6.0
  7. Other income+0.2
  8. One-off items0.0
  9. Finance costs−0.4
  10. Profit before tax−35
  11. Tax+0.5
  12. Net profit−34

What the company owns

  • Plant, investments and other assets₹64 Cr
  • Inventory₹2 Cr
  • Cash and bank₹1 Cr
  • Receivables₹0 Cr

What pays for it: net worth and liabilities

  • Net worth₹50 Cr
  • Borrowings₹10 Cr
  • Other liabilities₹5 Cr
  • Owed to suppliers₹2 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.Lasa Supergenerics quarterly results

₹ croreMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026Twelve months
Revenue from operations246170167202137130104142256
2051581371551211361021365415
Materials and goods bought1721289511291106751062410
Employee costs–1213141076621
Other expenses–19292920232124284
Operating profit before depreciation4111304716−726−28−9
Operating margin16.8%6.6%17.9%23.3%11.4%−5.1%2.1%4.4%−113.0%−137.2%
Materials, % of revenue–75.5%56.6%55.5%66.6%81.9%72.1%74.5%94.8%–
Employee costs, % of revenue–6.9%8.0%6.9%7.2%5.7%6.1%4.3%8.6%–
Other expenses, % of revenue–11.1%17.5%14.2%14.8%17.5%19.8%16.8%109.5%–
Depreciation and amortisation181917161413111266
Operating profit after depreciation23−813312−20−9−6−34−15
Other income3400020500
Finance costs111282042300
Profit before one-off items and tax15−165292−22−10−4−35−15
One-off items–000−8−20−9−1600
Profit before tax15−16529−6−42−19−19−35−16
3––––−43−5−11
Net profit12−12423−5−39−22−15−34−17
Other comprehensive income–000000000
Total comprehensive income–−12423−5−39−22−15−34−17
Net margin5.0%−7.1%2.2%11.3%−3.9%−29.8%−20.8%−10.4%−135.6%−260.4%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2018 they do not, so they are left blank. Tax is left blank for the years to Mar 2019, Mar 2020, Mar 2021 and Mar 2022: profit before tax less the tax charge stated does not come to the profit after tax the same statement states, so the tax charge is not shown.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
105141159149118978450
Share capital2341414150505050
Reserves821011181086847340
693400022310
10776414443491717
4615873510
Total assets25823220819916415110266
1731561441271251136956
8676647239383310
Net debt6628−4−17−22129
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the year to Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
41.310.5−33.52.1−2.8−22.8
41.313.1−13.62.1−2.8−22.8
−5.95.29.26.41.511.4
Receivables5.9−3.716.15.32.11.5
Inventories9.05.8−2.4−5.1−5.59.9
Payables−21.03.1−7.54.6−3.80.0
Other working capital0.10.13.01.68.70.0
Tax paid0.0−2.60.00.00.00.0
Capital spending6.62.34.80.70.00.0
Free cash flow34.78.2−38.31.5−2.8−22.8
−3.6−3.21.5−0.48.20.0
−36.40.04.2−1.9−5.70.0
Dividends paid0.0––0.00.00.0
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.00.00.00.00.0
Net change in cash1.37.2−27.8−0.2−0.3−22.8
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2018, Mar 2019 and Mar 2020. Dividends paid is left blank for the years to Mar 2022 and Mar 2023: the cash-flow statement states no dividends paid, while the company's own dividend record shows one paid in the period, so the line is not given.

Per share

Standalone, ₹ per share, years to March.Lasa Supergenerics dividend history

₹ per shareMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Earnings per share₹5.40−₹5.26₹1.26₹5.60−₹1.32−₹15.42−₹4.34−₹2.95−₹6.80
Diluted earnings per share₹5.40−₹5.26₹1.26₹5.60−₹1.32−₹15.42−₹4.34−₹2.95−₹6.80
Dividend per share–––₹0.25₹0.25––––
Book value per share–₹46.05₹34.78₹39.07₹36.54₹23.61₹19.30₹16.71₹9.90
Dividend payout–––4.5%–––––
Shareholder yield–––0.0%––0.0%0.0%0.0%
Market cap at the year end (₹ crore)2065162243170931108428
Shareholder yield is left blank for the years to Mar 2022 and Mar 2023: the cash-flow statement states no dividends paid, while the company's own dividend record shows one paid in the period, so the line is not given.

Ratios

Standalone, years to March.Lasa Supergenerics PE ratio and valuation

RatioMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue growth–−31.0%−1.4%21.0%−32.2%−5.5%−19.5%36.5%−82.4%
Operating profit growth–−73.1%169.6%57.7%−66.9%––189.3%–
Net profit growth–––527.8%–––––
Earnings per share growth–––344.4%–––––
–−11.4%2.9%15.2%−3.5%−28.9%−20.2%−16.4%−51.1%
––14.4 pts12.2 pts−18.7 pts−25.4 pts8.7 pts3.9 pts−34.8 pts
From the net margin––14.9 pts12.3 pts−20.4 pts−23.1 pts8.7 pts10.2 pts−197.8 pts
From asset turnover––0.1 pts5.3 pts1.4 pts−1.6 pts1.4 pts−7.1 pts157.3 pts
From borrowing––−0.7 pts−5.4 pts0.4 pts−0.8 pts−1.4 pts0.8 pts5.7 pts
Return on capital employed–−4.7%7.2%19.8%1.1%−16.9%−7.2%−7.0%−58.0%
Cash conversion–––181.4%–––––
Interest cover2.0–1.616.040.5––––
Debt to equity–0.650.240.000.000.000.230.030.20
Receivable days–6245274971341
Inventory days–90101564648928428
Payable days–170130416332683533
Cash conversion cycle, days–−18164132223753−4
Working capital days–−2313530−17344339
Asset turnover–0.660.680.920.670.710.661.130.30
Assets per rupee of net worth–2.451.991.461.321.361.461.401.26
Sales per rupee of plant–1.091.151.471.171.471.242.960.66
Capital spending to depreciation–––0.420.160.360.060.000.00
Plant being built, % of plant in use–4.5%–0.0%3.9%5.3%3.0%0.5%0.0%
Interest cover is left blank for the years to Mar 2019, Mar 2023, Mar 2024, Mar 2025 and Mar 2026: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the year to Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
−40.6%
Measure10 years5 years3 years
Revenue growth, yearly rate–−34.1%−42.1%
Return on equity, average–−24.0%−29.2%
Return on capital employed, average–−17.6%−24.0%
Operating margin, average−4.0%−20.0%−35.5%
Net margin, average−21.0%−40.1%−55.6%
Asset turnover, average–0.700.70
Cash conversion cycle, days, average–2829
Debt to equity, average–0.090.15

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−46.5−23.5−22.8
Cash from investing6.07.80.0
Cash from financing−3.5−7.60.0
Capital spending7.80.70.0
Dividends paid–0.00.0
Shares bought back0.00.00.0
Shares issued for cash0.00.00.0
Borrowings raised0.00.00.0
Borrowings repaid5.35.30.0

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9–––941543
Altman Z-scorePublished threshold 1.81–1.152.245.393.531.801.884.35−0.43
Beneish M-scorePublished threshold −1.78–––−3.01−1.96−1.68−3.16−3.09−3.68
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–––−6.79−6.20−3.66−14.92−15.92−13.43
Receivables growth less revenue growthOur threshold 0 percentage points––−27.14−49.4757.46−81.0964.24−94.94−14.89
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––9.26−53.09−14.644.6966.09−12.54−15.04
Other current assets growth less revenue growthOur threshold 5 per cent of revenue––0.112.49−2.30−3.32−6.41−5.648.55
Assets under construction, years of additionsOur threshold 2 years of additions–––0.00––0.39––
Effective tax ratePublished threshold 17.16 per cent18.99–15.6325.84–––––
A threshold marked as ours has no published figure; it is the line we read the check against.